Package 68788-8478-3

{"route": ["ORAL"], "spl_id": "07bad3ac-76c5-4a87-a0e2-e3d5baefee8b", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["485484"], "spl_set_id": ["ae9b6808-632f-4204-8581-bf146dcab69f"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (68788-8478-1)", "package_ndc": "68788-8478-1", "marketing_start_date": "20230706"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (68788-8478-3)", "package_ndc": "68788-8478-3", "marketing_start_date": "20230706"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE, PLASTIC (68788-8478-6)", "package_ndc": "68788-8478-6", "marketing_start_date": "20230706"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE, PLASTIC (68788-8478-9)", "package_ndc": "68788-8478-9", "marketing_start_date": "20230706"}], "brand_name": "TIZANIDINE HYDROCHLORIDE", "product_id": "68788-8478_07bad3ac-76c5-4a87-a0e2-e3d5baefee8b", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "68788-8478", "generic_name": "tizanidine hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TIZANIDINE HYDROCHLORIDE", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "6 mg/1"}], "application_number": "ANDA210267", "marketing_category": "ANDA", "marketing_start_date": "20230706", "listing_expiration_date": "20261231"}